This report examines the clinical utility of genetic testing of unaffected individuals at risk for hereditary breast and ovarian cancer syndrome due to family history. This report provides an assessment of the evidence for the use of genetic testing in this population. The goal of the report is to assess how genetic testing of unaffected patients changes patient management, informs treatment selection and/or prognosis, and impacts at-risk family members.

If you have a Hayes login, click here to view the full report on the Knowledge Center.